Blue Water Life Science Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-78,843
Closed -$4.43M 8
2024
Q4
$4.43M Sell
78,843
-176,400
-69% -$11M 3.92% 7
2024
Q3
$17.4M Buy
255,243
+197,900
+345% +$11.2M 15.29% 3
2024
Q2
$2.42M Hold
57,343
2.36% 7
2024
Q1
$3.96M Buy
+57,343
New +$3.63M 3.72% 7
2021
Q2
Sell
-166,957
Closed -$22M 25
2021
Q1
$22M Buy
166,957
+91,707
+122% +$12.6M 10.75% 5
2020
Q4
$9.97M Buy
+75,250
New +$9.1M 5.85% 9

Other funds holding EXAS

Blue Water Life Science Advisors's EXAS Position: Q1 2025 in Review

Blue Water Life Science Advisors sold out of Exact Sciences (EXAS) in Q1 2025, closing a stake of 78,843 shares — an estimated $4.43M sold.

Blue Water Life Science Advisors first reported a position in EXAS in Q4 2020 and held it in 6 quarters. The position peaked at $22M in Q1 2021. 558 funds tracked by Wall St. Rank hold EXAS as of Q1 2025.

  • Blue Water Life Science Advisors reported no remaining Exact Sciences position as of Q1 2025 after selling out during the quarter.
  • Blue Water Life Science Advisors sold 78,843 Exact Sciences shares in Q1 2025, an estimated $4.43M.
  • Blue Water Life Science Advisors first reported a position in Exact Sciences in Q4 2020 and held it in 6 quarters.
  • Blue Water Life Science Advisors's Exact Sciences position peaked at $22M in Q1 2021.
  • 558 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2025.

Based on Blue Water Life Science Advisors's 13F filing for Q1 2025, filed 15 May 2025.